Saudi Journal of Anaesthesia

ORIGINAL ARTICLE
Year
: 2015  |  Volume : 9  |  Issue : 3  |  Page : 258--262

Dexmedetomidine versus propofol in dilatation and curettage: An open-label pilot randomized controlled trial


Priyanka Sethi1, Sunil Sindhi2, Ankita Verma2, KL Tulsiani2 
1 Department of Anesthesiology, Dr. S.N. Medical College; Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
2 Department of Anesthesiology, Dr. S.N. Medical College, Jodhpur, Rajasthan, India

Correspondence Address:
Priyanka Sethi
Senior Resident, Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences, Jodhpur - 342 005, Rajasthan
India

Background: Traditionally propofol has been used for providing sedation in dilatation and curettage (D and C). Recently, dexmedetomidine has been tried, but very little evidence exists to support its use. Aims: The aim was to compare hemodynamic and recovery profile of both the drugs along with a degree of comfort experienced by patients and the usefulness of the drug to surgeons. Settings and Design: Tertiary care center and open-label randomized controlled trial. Materials and Methods: Patients posted for D and C were enrolled in two groups (25 each). Both groups received fentanyl 1 μg/kg intravenous (IV) at the beginning of the procedure. Group P received IV propofol in dose of 1.5 mg/kg over 10-15 min and Group D received dexmedetomidine at a loading dose of 1 μg/kg over 10 min, followed by 0.5 μg/kg/h infusion until Ramsay sedation score reached 3-4. Hemodynamic vitals were compared during and after the procedure. In the recovery room time to reach modified Aldrete score (MAS) of 9-10 and patient«SQ»s and surgeon«SQ»s satisfaction scores were also recorded and compared. Results: In Group D, patients had statistically significant lower heart rate at 2, 5, 10 and 15 min as compared to Group P. Hypotension was present in 52% in Group P and 4% in Group D (P < 0.05). MAS of 9-10 was achieved in 4.4 min in subjects in Group D in contrast to 16.2 min in Group P (P < 0.05). Group D showed higher patient and surgeon satisfaction scores (P < 0.05). Conclusion: Dexmedetomidine provide better hemodynamic and recovery profile than propofol. It can be a superior alternative for short surgical day care procedures.


How to cite this article:
Sethi P, Sindhi S, Verma A, Tulsiani K L. Dexmedetomidine versus propofol in dilatation and curettage: An open-label pilot randomized controlled trial.Saudi J Anaesth 2015;9:258-262


How to cite this URL:
Sethi P, Sindhi S, Verma A, Tulsiani K L. Dexmedetomidine versus propofol in dilatation and curettage: An open-label pilot randomized controlled trial. Saudi J Anaesth [serial online] 2015 [cited 2022 Aug 10 ];9:258-262
Available from: https://www.saudija.org/article.asp?issn=1658-354X;year=2015;volume=9;issue=3;spage=258;epage=262;aulast=Sethi;type=0